That's nice rob. I'll note that AGY also includes info wrt product sales and pricing (revenue) in their quarterly reports.
I'll also note that we do not have any regular shipments/sales, and that the few sales to-date have been for relatively small quantities at the testing and qualification scale.
You know this. Pierre knows this.
Nothing is being "hidden" as pierre suggests.
Let's see how that reporting evolves (in format and detail) as Rincon actually moves to become a commercial operation, and there is at least a steady-state operation to actually report details for, shall we...?
I expect the reporting details to be significantly different at that stage. Why would the company present misleading cost figures that are associated with sporadic production during testing and commissioning...?? That would certainly help to fuel the fearmongering wouldn't it?!
AGY Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)